Polatuzumab,Etoposide,Rituximab,Doxorubicin,Prednisone
roche,abbvie,biogen
['lymsm', 'dlbcl']
do we need to do another pola-epchr, maybe pola-chpr is enough in this high risk population. hope to see biology to justify the the regimen in dlbcl #lymsm #asco22 
A hematologist @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.